Ending the HIV Epidemic: A Plan for America — Ryan White HIV/AIDS Program Parts A and B

The purpose of this initiative is to focus resources in 48 counties, Washington, D.C., San Juan, Puerto Rico (PR), and seven states with the highest incidence or burden of HIV to implement effective and innovative strategies, interventions, approac

Ending the HIV Epidemic in the U.S. is the first federal initiative to focus on ending the HIV epidemic in the U.S. This program focuses resources in 48 counties, Washington, D.C., San Juan, Puerto Rico (PR), and seven states with substantial rural HIV burden to implement strategies, interventions, approaches, and provide core medical and support services to people with HIV to achieve the goals of the initiative.

U.S. Territories and possessions, State, Local (includes State-designated lndian Tribes, excludes institutions of higher education and hospitals Eligible applicants are: RWHAP Part A funded Eligible Metropolitan Areas (EMAs) or Transitional Grant Areas (TGAs) whose service area includes one or more of the identified 48 HIV high burden counties; and the EMAs of Washington, D.C. and San Juan, PR. RWHAP Part B funded States/Territories identified as having a substantial rural HIV burden: Alabama, Arkansas, Kentucky, Mississippi, Missouri, Oklahoma, and South Carolina and the RWHAP Part B Program of the State of Ohio on behalf of Hamilton County.

Individuals with HIV.

Funded recipients will use these initiative resources in conjunction with the RWHAP Parts A and B systems of HIV care and treatment to develop, implement, and/or enhance innovative approaches to engaging people with HIV in the focus jurisdictions who are newly diagnosed, not in care and/or not virally suppressed, as well as provide rapid access to a comprehensive continuum of high quality care. All funds under this notice are subject to the following conditions: Funds from this announcement may not pay for any item or service to the extent that payment has been made (or reasonably can be expected to be made), with respect to that item or service, under any state compensation program, insurance policy, federal or state benefits program, or any entity that provides health services on a prepaid basis (except for a program administered by or providing the services of the Indian Health Service). All providers of care will have a participation agreement under the State plan approved under title XIX of the Social Security Act, or, if not qualified to receive payments under such state plan, the provider does not, in providing health care services, impose a charge or accept reimbursement available from any third-party payor, including reimbursement under any insurance policy or under any Federal or State health benefits program. Prohibited uses of funds: o Cash payment to intended recipients of services. Clinical research. o International travel. o Construction (minor alterations and renovations to an existing facility to make it more suitable for the purposes of the award program are allowable with prior HRSA approval). o Syringe Services Programs (SSPs). o Pre Exposure Prophylaxis (PrEP) medications and related medical services or Post-Exposure Prophylaxis (PEP), as the person using PrEP or PEP is not living with HIV and therefore not eligible for HRSA HAB initiative funded medication, as outlined in the June 22, 2016 Program Letter . o Supplantation of funds for any other federal award or state funds.

Funded recipients will use these initiative resources in conjunction with the RWHAP Parts A and B systems of HIV care and treatment to develop, implement, and/or enhance innovative approaches to engaging people with HIV in the focus jurisdictions who are newly diagnosed, not in care and/or not virally suppressed, as well as provide rapid access to a comprehensive continuum of high quality care. All funds under this notice are subject to the following conditions: Funds from this announcement may not pay for any item or service to the extent that payment has been made (or reasonably can be expected to be made), with respect to that item or service, under any state compensation program, insurance policy, federal or state benefits program, or any entity that provides health services on a prepaid basis (except for a program administered by or providing the services of the Indian Health Service). All providers of care will have a participation agreement under the State plan approved under title XIX of the Social Security Act, or, if not qualified to receive payments under such state plan, the provider does not, in providing health care services, impose a charge or accept reimbursement available from any third-party payor, including reimbursement under any insurance policy or under any Federal or State health benefits program. Prohibited uses of funds: o Cash payment to intended recipients of services. Clinical research. o International travel. o Construction (minor alterations and renovations to an existing facility to make it more suitable for the purposes of the award program are allowable with prior HRSA approval). o Syringe Services Programs (SSPs). o Pre Exposure Prophylaxis (PrEP) medications and related medical services or Post-Exposure Prophylaxis (PEP), as the person using PrEP or PEP is not living with HIV and therefore not eligible for HRSA HAB initiative funded medication, as outlined in the June 22, 2016 Program Letter . o Supplantation of funds for any other federal award or state funds.

The EHE initiative began in FY 2020.

Preapplication coordination is required. Environmental impact information is not required for this program. This program is excluded from coverage under E.O. 12372. Applicants are encouraged to participate in the pre-application technical assistance call. Details will be provided in the Notice of Funding Opportunity (NOFO).

Procedures for assessing the technical merit of grant applications have been instituted to provide an objective review of applications and to assist the applicant in understanding the standards against which each application will be judged. Critical indicators have been developed for each review criterion to assist the applicant in presenting pertinent information related to that criterion and to provide the reviewer with a standard for evaluation. Competing applications are reviewed by nonfederal reviewers for technical merit recommendations. Applications will be reviewed and evaluated against the following criteria: (1) Purpose and Need; (2) Response to Program Purpose; (3) Impact; (4) Organizational Information, Resources and Capabilities; and (5) Support Requested. See the most recent NOFO for detailed review criteria.

Notification is made in writing (electronic) by a Notice of Award.

Awards will be made for up to 5 years, subject to the availability of funds. After initial awards, annual noncompetitive awards may be made contingent upon the submission of noncompetitive applications/progress reports, availability of funds, and the continued best interest of the federal government.